-transparent.png){kind=logo}
We examined the association of three serum immune markers with CD4 cell counts in a large cohort of i.v. drug users with and without human immunodeficiency virus (HIV) infection. Levels of beta 2-microglobulin and neopterin were significantly elevated in HIV-infected subjects and increased in association with decline in CD4 cell counts (all p less than 0.001). Serum IgA levels in HIV-seropositive individuals were significantly elevated only when the CD4 cell count was less than 200/microliters (p less than 0.001). After controlling for HIV status and CD4 count, recent history of hepatitis was associated with significantly higher beta 2-microglobulin (p = 0.028) and marginally higher neopterin (p = 0.052) levels. There was no association of race, gender, or drug use patterns with levels of serum immune markers after controlling for HIV status and CD4 count. These data indicate that immune activation is coupled with immunosuppression in HIV-infected i.v. drug users. In addition, beta 2-microglobulin and neopterin levels are elevated in persons with a recent history of hepatitis but not in those with recent non-AIDS-defining bacterial infections. Markers of immune activation do not vary by race, gender, or drug use patterns among i.v. drug users.
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
December 1992,
Journal of acquired immune deficiency syndromes,
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
October 1994,
Journal of acquired immune deficiency syndromes,
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
June 1992,
Recenti progressi in medicina,
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
March 1993,
The Journal of infection,
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
August 1991,
AIDS (London, England),
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
June 1995,
Polskie Archiwum Medycyny Wewnetrznej,
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
February 1994,
AIDS (London, England),
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
October 2000,
Journal of acquired immune deficiency syndromes (1999),
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
February 1996,
Addiction (Abingdon, England),
R E Chaisson, and
E Taylor, and
J B Margolick, and
A Muñoz, and
L Solomon, and
S Cohn, and
K E Nelson, and
D Vlahov
December 1994,
Immunology letters,
